RoukenBio

We take our tagline seriously. We’re disrupting the traditional CRO model with our collaborative, personalised approach to drug discovery. With customers in over 27 countries globally, our aim is to become the most trusted research partner to biotherapeutic innovators.

Backed by brilliant minds, we offer a range of in vitro bioassay services from immunology, bioanalytical, cell line engineering, development of bioassays, to safety and efficacy assessments. Working across inflammation, auto-immunity, immuno-oncology and oncology, we focus on novel and emerging therapeutic classes.

We embrace change and drive innovation with unique services, like our customisable IndEx-2 cell line platform, to stay ahead of the curve. Our assays recreate disease state pathologies as faithfully as possible, driving your drug discovery journey forward.